Metastatic Breast Cancer | Tumor

CURE’s metastatic breast cancer page features the latest cancer news and updates on metastatic breast cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in metastatic breast cancer.

FDA Approves New Dose of Herceptin Biosimilar

March 24th 2020, 6:34pm

Article

The Food and Drug Administration approved an updated dose of Ontruzant, a biosimilar to Herceptin, for multiple cancer types.

A Metastatic Breast Cancer Thriver Shares the Importance of Understanding Your Diagnosis

March 20th 2020, 12:00am

Video

Understanding a diagnosis is not just something for a patient's care team, the patient needs to understand their diagnosis as well.

Battling Cancer and Social Security

March 19th 2020, 10:00pm

Article

Advice to the Newly Diagnosed: Get a Second Opinion

March 14th 2020, 10:00pm

Video

Don’t be worried to get a second opinion — it could save your life.

Friday Frontline: Cancer Updates Amid COVID-19 Pandemic on March 13, 2020

March 13th 2020, 7:00pm

Article

The COVID-19 pandemic has reached across the globe and continues to change, rapidly impacting everyone. Here are some of the stories around the world highlighting how the pandemic has impacted the lives of patients with cancer.

Combination Therapy Shows Overall Survival Benefit in Advanced Breast Cancer

March 4th 2020, 9:00pm

Article

The combination of Kisqali and Faslodex shows improved overall survival in patients with hormone-receptor-positive, HER2-negative advanced breast cancer.

Novel HER-2 Targeted Agents Show Promise in Treating CNS Metastases

February 21st 2020, 2:57am

Video

A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.

Buses and Uncertainty

January 23rd 2020, 9:07pm

Article

21 Years of Breast Cancer Survivorship

January 15th 2020, 9:02pm

Article

CDK Inhibitors with Endocrine Therapy Show Survival Benefit in Patients with Metastatic Breast Cancer

January 15th 2020, 7:00pm

Article

Despite differences in tumors, the addition of CDK 4/6 inhibitors to endocrine therapy showed a benefit in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer compared with endocrine therapy alone.